Paper3965588
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
Bayer AS and 1 other. J Infect Dis, 1985. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. Papers, record 3965588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3965588
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endocarditis, Bacterial | Major topic |
| Rifampin | Major topic |
| Staphylococcal Infections | Major topic |
| Vancomycin | Major topic |
| Animals | |
| Creatinine | |
| Disease Models, Animal | |
| Drug Therapy, Combination | |
| Kidney | |
| Methicillin | |
| Microbial Sensitivity Tests | |
| Penicillin Resistance | |
| Rabbits | |
| Staphylococcus aureus |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37887720 | The In Vitro Antimicrobial Susceptibility of Borrelia burgdorferi sensu lato: Shedding Light on the Known Unknowns. | Pathogens | 2023 | https://conductscience.org/library/papers/37887720 | PubMed |
| 35129409 | Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials. | Expert Opin Investig Drugs | 2022 | https://conductscience.org/library/papers/35129409 | PubMed |
| 34223108 | Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections. | JAC Antimicrob Resist | 2021 | https://conductscience.org/library/papers/34223108 | PubMed |
| 34097491 | Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34097491 | PubMed |
| 32191760 | Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis. | PLoS One | 2020 | https://conductscience.org/library/papers/32191760 | PubMed |
| 24775563 | Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/24775563 | PubMed |
| 22553438 | Influence of rifampin therapy on serum bactericidal activity in the presence of cloxacillin and vancomycin. | Can J Infect Dis | 1990 | https://conductscience.org/library/papers/22553438 | PubMed |
| 21859940 | Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21859940 | PubMed |
| 20065324 | Rifampin combination therapy for nonmycobacterial infections. | Clin Microbiol Rev | 2010 | https://conductscience.org/library/papers/20065324 | PubMed |
| 19072553 | Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19072553 | PubMed |
| 17712583 | Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials. | Eur J Clin Microbiol Infect Dis | 2007 | https://conductscience.org/library/papers/17712583 | PubMed |
| 15388469 | In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15388469 | PubMed |
| 14506020 | Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/14506020 | PubMed |
| 12937013 | Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12937013 | PubMed |
| 12878535 | Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12878535 | PubMed |
| 11959588 | Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11959588 | PubMed |
| 11257041 | Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11257041 | PubMed |
| 10508047 | Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10508047 | PubMed |
| 9624475 | Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9624475 | PubMed |
| 9360059 | Recognition, management and prophylaxis of endocarditis. | Drugs | 1997 | https://conductscience.org/library/papers/9360059 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3965588
GET https://conductscience.org/api/papers/v1/3965588/cited_by?page=2